APA Alıntı

Dehdashti, F., Wu, N., Bose, R., Naughton, M. J., Ma, C. X., Marquez-Nostra, B. V., . . . Siegel, B. A. (2018). Evaluation of [(89)Zr]Trastuzumab-PET/CT in Differentiating HER2-Positive from HER2-Negative Breast Cancer. Breast Cancer Res Treat.

Chicago Stili Alıntı

Dehdashti, Farrokh, et al. "Evaluation of [(89)Zr]Trastuzumab-PET/CT in Differentiating HER2-Positive From HER2-Negative Breast Cancer." Breast Cancer Res Treat 2018.

MLA Alıntı

Dehdashti, Farrokh, et al. "Evaluation of [(89)Zr]Trastuzumab-PET/CT in Differentiating HER2-Positive From HER2-Negative Breast Cancer." Breast Cancer Res Treat 2018.

Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..